# Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

> **NCT05338047** · PHASE2 · COMPLETED · sponsor: **Hospital Universitario Dr. Jose E. Gonzalez** · enrollment: 30 (actual)

## Conditions studied

- Myeloma Multiple
- Lymphoma

## Interventions

- **DRUG:** Pegfilgrastim

## Key facts

- **NCT ID:** NCT05338047
- **Lead sponsor:** Hospital Universitario Dr. Jose E. Gonzalez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-02-25
- **Final completion:** 2023-02-25
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05338047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05338047, "Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05338047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*